Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Luther

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
American Journal of Hypertension|September 1, 1989
New perspectives on selective alpha 1 blockadeR R Luther
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1989
Terazosin: a new antihypertensive agent with favorable effects on lipidsR R Luther
Archives of Internal Medicine|September 1, 1974
Acute mitral insufficiency secondary to ruptured chrodae tendineaeR R Luther, S N Meyers
Anesthesia and Analgesia|July 1, 1976
Anaphylaxis: etiology and guidelines for managementD H Morrow, R R Luther
Drugs of Today (Barcelona, Spain : 1998)|March 11, 2004
The management of severe chronic pain with a focus on new treatment modalitiesD McGuire, R R Luther, M DuBois
Brain Research|February 7, 1997
Selective blockade of N-type voltage-sensitive calcium channels protects against brain injury after transient focal cerebral ischemia in ratsS S Bowersox, T Singh, R R Luther
Clinical Nephrology|October 1, 1991
Renin inhibitors in hypertensionR R Luther, H N Glassman, R S Boger
The American Journal of Medicine|May 23, 1986
Clinical trials with terazosin. General methodsW D Sperzel, R R Luther, H N Glassman
Journal of Clinical Pharmacology|July 1, 1988
A comparison of carteolol and nadolol in the treatment of stable angina pectorisR R Luther, H N Glassman, D C Jordan
Journal of Cardiovascular Pharmacology|September 23, 1997
Sympatholysis after neuron-specific, N-type, voltage-sensitive calcium channel blockade: first demonstration of N-channel function in humansD McGuire, S Bowersox, J D Fellmann, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
American Journal of Hypertension|September 1, 1989
New perspectives on selective alpha 1 blockadeR R Luther
International Journal of Clinical Pharmacology, Therapy, and Toxicology|July 1, 1989
Terazosin: a new antihypertensive agent with favorable effects on lipidsR R Luther
Archives of Internal Medicine|September 1, 1974
Acute mitral insufficiency secondary to ruptured chrodae tendineaeR R Luther, S N Meyers
Anesthesia and Analgesia|July 1, 1976
Anaphylaxis: etiology and guidelines for managementD H Morrow, R R Luther
Drugs of Today (Barcelona, Spain : 1998)|March 11, 2004
The management of severe chronic pain with a focus on new treatment modalitiesD McGuire, R R Luther, M DuBois
Brain Research|February 7, 1997
Selective blockade of N-type voltage-sensitive calcium channels protects against brain injury after transient focal cerebral ischemia in ratsS S Bowersox, T Singh, R R Luther
Clinical Nephrology|October 1, 1991
Renin inhibitors in hypertensionR R Luther, H N Glassman, R S Boger
The American Journal of Medicine|May 23, 1986
Clinical trials with terazosin. General methodsW D Sperzel, R R Luther, H N Glassman
Journal of Clinical Pharmacology|July 1, 1988
A comparison of carteolol and nadolol in the treatment of stable angina pectorisR R Luther, H N Glassman, D C Jordan
Journal of Cardiovascular Pharmacology|September 23, 1997
Sympatholysis after neuron-specific, N-type, voltage-sensitive calcium channel blockade: first demonstration of N-channel function in humansD McGuire, S Bowersox, J D Fellmann, et al.
Pageof 5